Inspirata Receives Growth Financing From Montage Capital

Inspirata, a leading provider of oncology informatics and cancer reporting compliance solutions for large hospitals, health systems and cancer centers, has received a round of debt financing from Montage Capital.

• Proven, sticky AI/NLP engine optimized for clinical cases built on top of a vendor-agnostic and scalable technology platform
• The company plans to use the capital to build out its go-to-market engine for its newly launched Clinical Trial Navigator product and continue to mine upsell opportunities for its E-Path (pathology report analysis software) and E-Path Plus (cancer registry reporting) products

About Inspirata

With over 20 years of industry experience, Inspirata provides AI-driven oncology informatics solutions trusted by 275+ leading healthcare providers worldwide. Developed in collaboration with leading healthcare institutions and government agencies, Inspirata’s proprietary NLP engine powers a suite of software solutions, including clinical trial matching, cancer registry reporting, and pathology report analysis. These solutions streamline workflows, improve data accuracy, and enhance patient outcomes by leveraging scalable AI and automation.

For more information, please visit Inspirata’s website.

About Montage Capital

Montage Capital is a leading provider of minimally dilutive growth capital to technology and life science companies. Montage’s debt-oriented funding solutions allow founders, management teams and early investors to maintain control and ownership of their companies, while obtaining the capital they need for growth. Based in Cupertino, California, Montage is well-positioned to support the increasing number of founder/angel funded companies which are revenue-generating, near cashflow breakeven, and do not require significant additional capital to achieve their next set of milestones.

For more information, please visit Montage Capital’s website.